NIH-funded research U01 cooperative agreement

Genetics of OCD in Latin American and diverse populations

Official title: 1/2 Trans-ancestry genomic analysis of obsessive-compulsive disorder

Funded at Univ of North Carolina Chapel Hill · NIH-11113931 · Data updated 2026-11-12

Researchers are finding how genes influence the risk of obsessive-compulsive disorder in people from Latin America and other ancestries by collecting DNA and clinical information.

More Obsessive-Compulsive Disorder research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 1, 2021
Project endJune 30, 2026
Funding year2025
Award (this year)$386,089
NIH project number5U01MH125050-05
Project IDNIH-11113931 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people diagnosed with obsessive-compulsive disorder, especially those of Latin American ancestry or who can enroll through participating clinics or online recruitment.

Less likely to help

People without OCD or those unwilling to provide a DNA sample and clinical information are unlikely to have a direct role or benefit from this project.

What this research studies

Researchers will enroll about 5,000 people with OCD through clinics across Latin America, partner U.S. clinics, and web-based recruitment, and collect detailed clinical information and DNA samples. All samples will be genotyped and analyzed in a trans-ancestry framework to find genetic variants and biological pathways linked to OCD. Clinical data will include symptom patterns, comorbid conditions, and other relevant medical history to relate genetics to how OCD presents. Increasing the size and ancestral diversity of the dataset aims to reveal signals missed by smaller or less diverse studies.

Why it matters

Potential benefit: If successful, the work could reveal genetic contributors to OCD that eventually inform better diagnosis, prevention, or new treatment targets.

How similar studies have gone: Large psychiatric genomics projects have identified risk genes for disorders like schizophrenia and autism, while OCD has had smaller genetic studies, making this large, diverse approach relatively novel but grounded in prior successes.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Crowley, James Joseph — Univ of North Carolina Chapel Hill
  • Study coordinator: Crowley, James Joseph

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.